MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1089/ars.2021.0105

Медицинская библиотека · Antioxidants & redox signaling · 2022

YB-1 Recruits Drosha to Promote Splicing of pri-miR-192 to Mediate the Proangiogenic Effects of H2S.

Zhou Yu, Li Xing-Hui, Xue Wen-Long, Jin Sheng, Li Meng-Yao, Zhang Cai-Cai, Yu Bo, Zhu Lei, Liang Kun, Chen Ying, Tao Bei-Bei, Zhu Yi-Zhun, Wang Ming-Jie, Zhu Yi-Chun

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Aims: The genes targeted by miRNAs have been well studied. However, little is known about the feedback mechanisms to control the biosynthesis of miRNAs that are essential for the miRNA feedback networks in the cells. In this present study, we aimed at examining how hydrogen sulfide (H2S) promotes angiogenesis by regulating miR-192 biosynthesis.

Results

H2S promoted in vitro angiogenesis and angiogenesis in Matrigel plugs embedded in mice by upregulating miR-192. Knockdown of the H2S-generating enzyme cystathionine γ-lyase (CSE) suppressed in vitro angiogenesis, and this suppression was rescued by exogenous H2S donor NaHS. Plakophilin 4 (PKP4) served as a target gene of miR-192. H2S up-regulated miR-192 via the VEGFR2/Akt pathway to promote the splicing of primary miR-192 (pri-miR-192), and it resulted in an increase in both the precursor- and mature forms of miR-192. H2S translocated YB-1 into the nuclei to recruit Drosha to bind with pri-miR-192 and promoted its splicing. NaHS treatment promoted angiogenesis in the hindlimb ischemia mouse model and the skin-wound-healing model in diabetic mice, with upregulated miR-192 and downregulated PKP4 on NaHS treatment. In human atherosclerotic plaques, miR-192 levels were positively correlated with the plasma H2S concentrations. Innovation and

Conclusion

Our data reveal a role of YB-1 in recruiting Drosha to splice pri-miR-192 to mediate the proangiogenic effect of H2S. CSE/H2S/YB-1/Drosha/miR-192 is a potential therapeutic target pathway for treating diseases, including organ ischemia and diabetic complications. Antioxid. Redox Signal. 36, 760-783. The Clinical Trial Registration number is 2016-224.

Для цитирования: Zhou Yu, Li Xing-Hui, Xue Wen-Long, Jin Sheng, Li Meng-Yao, Zhang Cai-Cai, Yu Bo, Zhu Lei, Liang Kun, Chen Ying, Tao Bei-Bei, Zhu Yi-Zhun, Wang Ming-Jie, Zhu Yi-Chun. YB-1 Recruits Drosha to Promote Splicing of pri-miR-192 to Mediate the Proangiogenic Effects of H2S.. Antioxidants & redox signaling. 2022. DOI: 10.1089/ars.2021.0105.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.